Shenzhen Stock Exchange: Genscript Biotech (01672) and Xizhi Technology (01879) will be included as eligible stocks for the Hong Kong Stock Connect under the Shenzhen-Hong Kong Stock Connect.
According to the relevant provisions of the "Implementation Measures for Shenzhen-Hong Kong Stock Connect" by the Shenzhen Stock Exchange, the list of eligible securities for the Hong Kong Stock Connect will be adjusted and come into effect on September 7, 2026.
On September 7, the Shenzhen Stock Exchange announced that, in accordance with the relevant provisions of the "Implementation Measures for Shenzhen-Hong Kong Stock Connect," the list of eligible securities for the Hong Kong stock connect has been adjusted and will take effect from September 7, 2026. The new additions include Galactech Pharmaceuticals (01672), Xizhi Technology (01879), and Baidu Group (09888), while NISSIN FOODS (01475), HAICHANG HLDG (02255), and SYNAGISTICS (02562) will be removed.
Related Articles
Beyond Zhihu (02390) financial reports: Reunderstanding the long-term value of a content community.
TECHTRONIC IND (00669) repurchased 50,000 shares for HKD 6.6845 million on September 7.
CHINA BOTON (03318) spent HKD 822,500 to buy back 278,000 shares on September 7.
Beyond Zhihu (02390) financial reports: Reunderstanding the long-term value of a content community.
TECHTRONIC IND (00669) repurchased 50,000 shares for HKD 6.6845 million on September 7.
CHINA BOTON (03318) spent HKD 822,500 to buy back 278,000 shares on September 7.
RECOMMEND
